Lv31
210 积分 2025-07-11 加入
Targeting therapeutic agent against C3b/C4b, SB002, on the inflammation‐induced bone loss in experimental periodontitis
2个月前
已完结
Arginine-Rich Peptides Regulate the Pathogenic Galectin-10 Crystallization and Mitigate Crystallopathy-Associated Inflammation
8个月前
已完结
IL-13 Controls IL-33 Activity through Modulation of ST2
10个月前
已完结
IL-33 released during challenge phase regulates allergic asthma in an age-dependent way
11个月前
已完结
Itch: Pathogenesis and treatment
11个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
1年前
已完结
Cancer cachexia
1年前
已完结
Strategies targeting IL-33/ST2 axis in the treatment of allergic diseases
1年前
已完结
皖公网安备34019202002308
